Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total ...
Hosted on MSN1mon
SNN Stock May Gain on CORIOGRAPH Platform's FDA Clearance for THASmith & Nephew SNATS SNN recently announced the FDA ... personalization of joint replacement surgeries. Integrated with the CORI Surgical System, it enables surgeons to create patient-specific ...
Hosted on MSN1mon
SNN Stock Might Rise Following FDA Nod for AETOS StemlessThe AETOS Shoulder System, including AETOS Stemless ... Under the agreement, JointVue’s technology allowed surgeons to use Smith+Nephew’s CORI Surgical System for robotic-assisted knee ...
Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty
Latest expansion to the CORI Surgical System portfolio provides a personalized solution for patients and surgeons Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company ...
It makes sense then that Smith+Nephew, a specialist in advanced wound ... that tennis players suffer are rotator cuff tears in the shoulder and meniscus tears in the knee, although, in Murray ...
JointVue’s technology allows surgeons using Smith+Nephew’s CORI Surgical System for robotic-assisted knee arthroplasty to create a personalized surgical plan, which may provide ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total ...
Latest expansion to the CORI Surgical System portfolio provides a personalized solution for patients and surgeons Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback